Procter & Gamble Health Limited
Bombay Stock ExchangeTotal Valuation
Procter & Gamble Health Limited carries a market capitalization of 104.98B, placing it among publicly traded companies globally. Its enterprise value stands at 77.65B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 104.98B |
| Enterprise Value | 77.65B |
Share Statistics
Procter & Gamble Health Limited currently has 16.60M shares outstanding.
| Shares Outstanding | 16.60M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
Procter & Gamble Health Limited trades at a trailing price-to-earnings ratio of 24.34. The price-to-sales ratio is 5.65, and the price-to-book ratio stands at 479.35.
| PE Ratio | 24.34 |
| PS Ratio | 5.65 |
| PB Ratio | 479.35 |
| P/TBV Ratio | 15.18 |
| P/FCF Ratio | N/A |
| P/OCF Ratio | N/A |
Enterprise Valuation
On an enterprise value basis, Procter & Gamble Health Limited trades at an EV/EBITDA multiple of 17.93 and an EV/FCF ratio of 19,428.16. The EV/Sales ratio of 5.52 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 17.93 provides insight into valuation relative to core operating earnings.
| EV / Sales | 5.52 |
| EV / EBITDA | 17.93 |
| EV / EBIT | 17.93 |
| EV / FCF | 19,428.16 |
Financial Position
Procter & Gamble Health Limited maintains a current ratio of 2.18, meaning it holds 2.2x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 1.77, indicating elevated leverage, while an interest coverage ratio of 787.40 demonstrates strong ability to service its debt obligations.
| Current Ratio | 2.18 |
| Quick Ratio | 0.79 |
| Debt / Equity | 1.77 |
| Debt / EBITDA | 0.02 |
| Interest Coverage | 787.40 |
Financial Efficiency
Procter & Gamble Health Limited posts a return on equity of 1,969.34 and a return on invested capital of 57.71.
| Return on Equity (ROE) | 1,969.34 |
| Return on Assets (ROA) | 39.98 |
| Return on Invested Capital (ROIC) | 57.71 |
| Return on Capital Employed (ROCE) | 1,306.36 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 2.97 |
Taxes
Over the trailing twelve months, Procter & Gamble Health Limited has paid 1.23B in income taxes, reflecting an effective tax rate of 27.33.
| Income Tax | 1.23B |
| Effective Tax Rate | 27.33 |
Stock Price Statistics
Procter & Gamble Health Limited's stock has gained approximately 9.48801% over the past 52 weeks. The 50-day moving average sits at 5,820.84, while the 200-day moving average is 5,608.19.
| Beta (5Y) | N/A |
| 52-Week Price Change | 9.48801% |
| 50-Day Moving Average | 5,820.84 |
| 200-Day Moving Average | 5,608.19 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Procter & Gamble Health Limited generated 14.08B in revenue and converted that into 3.27B in net income, yielding earnings per share of 197.12. EBITDA reached 4.33B, while operating income came in at 4.33B.
| Revenue | 14.08B |
| Gross Profit | 10.43B |
| Operating Income | 4.33B |
| Pretax Income | 4.50B |
| Net Income | 3.27B |
| EBITDA | 4.33B |
| EBIT | 4.33B |
| Earnings Per Share (EPS) | 197.12 |
Balance Sheet
Procter & Gamble Health Limited holds 2.01B in cash and equivalents against 92.90M in total debt, resulting in a net debt position of -1.77B. Total book value stands at 166.00M, with working capital of 3.01B providing operational flexibility.
| Cash & Cash Equivalents | 2.01B |
| Total Debt | 92.90M |
| Net Debt | -1.77B |
| Equity (Book Value) | 166.00M |
| Book Value Per Share | 10.01 |
| Working Capital | 3.01B |
Margins
Procter & Gamble Health Limited operates with a gross margin of 74.07, reflecting its pricing power and cost economics. The operating margin of 30.76 and net profit margin of 23.22 provide insight into operational efficiency.
| Gross Margin | 74.07 |
| Operating Margin | 30.76 |
| Pretax Margin | 31.95 |
| Profit Margin | 23.22 |
| EBITDA Margin | 30.76 |
Scores
Procter & Gamble Health Limited posts an Altman Z-Score of 18.87, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 18.87 |